Regulation of neutrophil apoptosis via death receptors

Cellular and Molecular Life Sciences

Volumn 60, Issue 11, 2003, Pages 2402-2408

  Akgul, C ^a   Edwards, S W ^b  

^a ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anti TNF ; Apoptosis; Death receptor; Fas; Neutrophil; Protein kinase; TNF

Indexed keywords

CELL SURFACE RECEPTOR; DEATH RECEPTOR 3; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DEATH RECEPTOR 6; FAS ANTIGEN; RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; BINDING AFFINITY; CELL ASSAY; CELL FATE; CELL MIGRATION; CELL SURVIVAL; HUMAN; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; HUMANS; NEUTROPHILS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION;

EID: 0344393518     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3110-z     Document Type: Review

References (58)

1. Edwards S. W. (1994) Biochemistry and Physiology of the Neutrophil, Cambridge University Press. New York
2. Savill J. and Haslett C. (1995) Granulocyte clearance by apoptosis in the resolution of apoptosis. Semin. Cell Biol. 6: 385-393
3. Akgul C., Moulding D. A. and Edwards S. W. (2001) Molecular control of neutrophil apoptosis. FEBS Lett. 487: 318-322
4. Ashkenazi A. and Dixit V. M. (1998) Death receptors: signalling and modulation. Science 281: 1305-1308
5. Tsujimoto Y. and Shimizu S. (2000) Bcl-2 family: life-or-death switch. FEBS Lett. 466: 6-10
6. Gross A., Yin X. M., Wang K., Wei M. C., Jockel J., Milliman C. et al. (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumour necrosis factor-R1/Fas death. J. Biol. Chem. 274: 1156-1163
7. Liles W. C., Kiener P. A., Ledbetter J. A., Aruffo A., Klebanoff S. J. (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184: 429-440
8. Murray J., Barbara J. A., Dunkley S. A., Lopez A. F., Van Ostade X., Condliffe A. M. et al. (1997) Regulation of neutrophil apoptosis by tumour necrosis factor-α: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90: 2772-2783
9. Nagata S. (1997) Apoptosis by death factor. Cell 88: 355-365
10. Medema J. P., Scaffidi C., Kischkel F. C., Shevchenko A., Mann M., Krammer P. H. et al. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794-2804
11. Muzio M. Stockwell B. R., Stennicke H. R., Salvesen G. S., Dixit V. M. (1998) An induced proximity model for caspase-8 activation. J. Biol. Chem. 273: 2926-2930
12. Ward C., Chilvers E. R., Lawson M. F., Pryde J. G., Fujihara S., Farrow S. N. et al. (1999) NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 274: 4309-4318
13. Zong W. X., Edelstein L. C., Chen C., Bash J., Gélinas C. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-α-induced apoptosis. Genes Dev. 13: 382-387
14. Brown S. B. and Savill J. (1999) Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J. Immunol. 162: 480-485
15. Renshaw S. A., Timmons S. J., Eaton V., Usher L. R., Akil M., Bingle C. D. et al. (2000) Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor. J. Leukoc. Biol. 67: 662-668
16. Serrao K. L., Fortenberry J. D., Owens M. L., Harris F. L., Brown L. A. (2001) Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am. J. Physiol. Lung Cell Mol. Physiol. 280: 298-305
17. Seino K., Iwabuchi K., Kayagaki N., Miyata R., Nagaoka I., Matsuzawa A. et al. (1998) Chemotactic activity of soluble Fas ligand against phagocytes. J. Immunol. 161: 4484-4488
18. Ottonello L., Tortolina G., Amelotti M., Dallegri F. (1999) Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J. Immunol 162: 3601-3606
19. O'Connell J. (2001) Role of Fas/FasL in inflammatory disease. Exp. Rev. Mol. Med. 10 December, http://www-ermm.cbcu.cam.ac.uk/01003969h.htm
20. Villunger A., O'Reilly L. A., Holler N., Adams J., Strasser A. (2000) Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: regulators of distinct cell death and survival pathways in granulocytes. J. Exp. Med. 192: 647-657
21. Fadeel B., Ahlin A., Henter J. I., Orrenius S., Hampton M. B. (1998) Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 92: 4808-4818
22. Khwaja A. and Tatton L. (1999) Caspase-mediated proteolysis and activation of protein kinase C-δ plays a central role in neutrophil apoptosis. Blood 94: 291-301
23. Kasahara Y., Iwai K., Yachie A., Ohta K., Konno A., Seki H. et al. (1997) Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 89: 1748-1753
24. Frasch S. C., Nick J. A., Fadok V. A., Bratton D. L., Worthen G. S., Henson P. M. (1998) p38-mitogen-activated protein kinase-dependent and independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273: 8389-8397
25. Aoshiba K., Yasui S., Hayashi M., Tamaoki J., Nagai A. (1999) Role of p38-mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils. J. Immunol. 162: 1692-1700
26. Juo P., Kuo C. J., Reynold S. E., Konz R. F., Raingeaud J., Davis R. T. et al. (1997) Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol. 17: 24-35
27. Alvarado-Kristensson M., Porn-Ares M. I., Grethe S., Smith D., Zheng L., Andersson T. (2002) p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J. 16: 129-131
28. Greenstein S., Barnard J., Zhou K., Fong M., Hendey M. (2000) Fas activation reduces neutrophil adhesion to endothelial cells. J. Leukoc. Biol. 68: 715-722
29. Hendey B., Zhu C. L., Greenstein S. (2002) Fas activation opposes PMA-stimulated changes in the localization of PKCδ: a mechanism for reducing neutrophil adhesion to endothelial cells. J. Leukoc. Biol. 71: 863-870
30. Watson R. W., O'Neill A., Brannigen A. E., Coffey R., Marshall J. C., Brady H. R. et al. (1999) Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent. FEBS Lett. 453: 67-71
31. Fang L., Fang J. and Chen C. Q. (2001) TNF receptor-associated factor-2 binding site is involved in TNFR75-dependent enhancement of TNFR55-induced cell death. Cell Res. 11: 217-222
32. Berg J. M. van den, Weyer S., Weening J. J., Roos D., Kuijpers T. W. (2001) Divergent effects of tumor necrosis factor α on apoptosis of human neutrophils. J. Leukoc. Biol. 69: 467-473
33. Salamone G., Giordano M., Trevani A. S., Gamberale R., Vermuelen M., Schettini J. (2001) Promotion of neutrophil apoptosis by TNF-α. J. Immunol. 166: 3476-3483
34. Porteu, F., Nathan, C. (1990) Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172: 599-607
35. Dri P., Gasparini C., Menegazzi R., Cramer R., Albert L., Presani G. et al. (2000) TNF-induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase. J. Immunol. 165: 2165-2172
36. Daigle I., Yousefi S., Colonna M., Green D. R., Simon H. U. (2002) Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat. Med. 8: 61-67
37. Lee H. H., Dadgostar H., Cheng Q., Shu J., Cheng G. (1999) NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signalling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96: 9136-9141
38. Moulding D. A., Akgul C., Derouet M., White M. R., Edwards S. W. (2001) BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J. Leukoc. Biol. 70: 783-792
39. Akgul C., Turner P. C., White M. R. H., Edwards S. W. (2000) Functional analysis of the human MCL-1 gene. Cell. Mol. Life Sci. 57: 684-691
40. Dunican A. L., Leuenroth S. J., Grutkoski P., Ayala A., Simms H. H. (2000) TNFα-induced suppression of PMN apoptosis is mediated through interleukin-8 production. Shock 14: 284-289
41. Zu Y. L., Qi J., Gilchrist A., Fernandez G. A., Vazquez-Abad D., Kreutzer D. L. et al. (1998) p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation. J. Immunol. 160: 1982-1989
42. Liu C. Y., Takemasa A., Liles W. C., Goodman R. B., Jonas M., Rosen H. et al. (2002) Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-alpha-stimulated neutrophils. Blood 101: 295-304
43. Maianski N. A., Roos D., Kuijpers T. W. (2003) Tumor necrosis α induces a caspase-independent death pathway in human neutrophils. Blood 101: 1987-1995
44. Yamashita K., Takahashi A., Kobayashi S., Hirata H., Mesner P. W., Kaufmann S. H. et al. (1999) Caspases mediate tumor necrosis factor-α-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood 93: 674-685
45. Waterman W. H., Molski T. F., Huang C. K., Adams J. L., Sha'afi R. I. (1996) Tumour necrosis factor-α-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem. J. 319: 17-20
46. McLeish K. R., Knall C., Ward R. A., Gerwins P., Coxon P. Y., Klein J. B. et al. (1998) Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-α and GM-CSF. J. Leukoc. Biol. 64: 537-545
47. Suzuki K., Hino M., Hato F., Tatsumi N., Kitagawa S. (1999) Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-α. Blood 93: 341-349
48. Avdi N. J., Nick J. A., Whitlock B. B., Billstrom M. A., Henson P. M., Johnson G. L. et al. (2001) Tumor necrosis factor-α activation of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases to apoptosis. J. Biol. Chem. 276: 2189-2199
49. Das S., Bhattacharyya S., Ghosh S., Majumdar S. (1999) TNF-α induced altered signaling mechanism in human neutrophil. Mol. Cell. Biochem. 197: 97-108
50. Kilpatrick L. E., Lee J. Y., Haines K. M., Campbell D. E., Sullivan K. E., Korchak H. M. (2002) A role for PKC-δ and PI 3-kinase in TNF-α-mediated antiapoptotic signaling in the human neutrophil. Am. J. Physiol. Cell Physiol. 283: 48-57
51. Cowburn A. S., Cadwallader K. A., Reed B. J., Farahi N., Chilvers E. R. (2002) Role of PI3-kinase-dependent Bad phosphorylation and altered transcription in cytokine-mediated neutrophil survival. Blood 100: 2607-2616
52. Daigle I. and Simon H. U. (2001) Alternative functions for TRAIL receptors in eosinophils and neutrophils. Swiss Med. Wkly 131: 231-237
53. Renshaw S. A., Parmar J. S., Singleton V., Rowe S. J., Dockrell D. H., Dower S. K. et al. (2003) Acceleration of human neutrophil apoptosis by TRAIL. J. Immunol. 170: 1027-1033
54. Edwards S. W. and Hallett M. B. (1997) Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today 18: 320-324
55. Goldenberg M. M. (1999) Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin. Ther. 21: 75-87
56. Bondeson J., Maini R. N. (2001) Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE). Int. J. Clin. Pract. 55: 211-216
57. Brannigan A. E., O'Connell P. R., Hurley H, O'Neill A., Brady H. R., Fitzpatrick J. M. et al. (2000) Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 13: 361-366
58. Taylor P. C., Peters A. M., Paleolog E., Chapman P. T., Elliott M. J., McCloskey R. et al. (2000) Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis. Arthritis Rheum. 43: 38-47